Crescendo Health Appoints David Strutton, PhD as Chief Scientific Officer
Crescendo Health, a leader in modernizing clinical research data infrastructure, today announced the appointment of David Strutton, PhD, as Chief Scientific Officer (CSO). In this role, Dr. Strutton will lead the company’s scientific strategy, evidence generation frameworks, and customer solutions to advance patient-centric clinical research.
Crescendo Health Welcomes Senior Executive Leading Partnerships and Business Development
Crescendo Health, a technology company powering the next generation of clinical studies, today announced T Hephner has joined the company as Head of Partnerships and Business Development. T previously served as the Chief Commercial officer at Curebase, and in senior leadership roles at Thread Research, Signant Health, and mProve.
Crescendo Health Launches to Improve and Accelerate Clinical Trials By Unlocking Patient Health Data
Crescendo Health, an innovative health data company powering the next generation of clinical research, today announced its official launch with a mission to revolutionize how patients contribute real-world data to clinical studies. The company also announced an initial $3.4 million investment from leading early-stage investors, including Define Ventures as well as the founders and CEOs of many other well-known organizations.
